March 24, 2017 2:11 PM ET


Company Overview of Icogenex Corporation

Company Overview

Icogenex Corporation, a biotechnology company, identifies and develops therapeutic compounds for the treatment of human diseases. The company provides research and development in the fields of Alzheimer's disease and inflammation, as well as produces therapeutic proteins from bacteria, yeast, or mammalian cells. Its products are used to treat inflammatory diseases, Alzheimer's disease, and diseases involving inappropriate proteolytic processing. Icogenex was formerly known as Icogen Corporation and changed its name in February 2004. The company was founded in 1995 and is headquartered in Seattle, Washington.

454 North 34th Street

Seattle, WA 98103

United States

Founded in 1995





Key Executives for Icogenex Corporation

Founder, Chief Executive Officer, President and Director
Chief Financial Officer
Age: 69
Director of Business Development
Compensation as of Fiscal Year 2016.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3Bar Biologics Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Icogenex Corporation, please visit Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at